ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
Pliant Therapeutics Inc

Pliant Therapeutics Inc (PLRX)

14.67
-0.84
( -5.42% )
업데이트: 03:35:17

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

주요 통계 및 세부정보

가격
14.67
매수가
14.65
매도가
14.69
거래량
311,632
14.66 일간 변동폭 15.80
10.29 52주 범위 19.62
market_cap
전일 종가
15.51
개장가
15.47
최근 거래 시간
1
@
14.67
마지막 거래 시간
03:35:25
재정 규모
US$ 4,721,158
VWAP
15.1498
평균 볼륨(3m)
450,880
발행 주식
60,853,623
배당수익률
-
주가수익률
-5.63
주당순이익(EPS)
-2.65
매출
1.58M
순이익
-161.34M

Pliant Therapeutics Inc 정보

Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis. Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
본부
Dover, Delaware, USA
설립됨
-
Pliant Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker PLRX. The last closing price for Pliant Therapeutics was US$15.51. Over the last year, Pliant Therapeutics shares have traded in a share price range of US$ 10.29 to US$ 19.62.

Pliant Therapeutics currently has 60,853,623 shares in issue. The market capitalisation of Pliant Therapeutics is US$943.84 million. Pliant Therapeutics has a price to earnings ratio (PE ratio) of -5.63.

PLRX 최신 뉴스

Pliant Therapeutics to Participate in Upcoming Investor Events

SOUTH SAN FRANCISCO, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company and leader in the discovery and development of...

Pliant Therapeutics Presents Data from its Bexotegrast Program at The Liver Meeting® 2024

INTEGRIS-PSC featured in an oral late breaker presentation SOUTH SAN FRANCISCO, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology...

Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

BEACON-IPF Phase 2b trial on track for full enrollment in the first quarter of 2025 with data anticipated in mid-2026 SOUTH SAN FRANCISCO, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Pliant...

Pliant Therapeutics to Participate in the Stifel Healthcare Conference

SOUTH SAN FRANCISCO, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), today announced that Keith Cummings, M.D., Chief Financial Officer, and Greg Cosgrove, M.D. FCCP...

Pliant Therapeutics INTEGRIS-PSC Phase 2a Data Evaluating Bexotegrast in Primary Sclerosing Cholangitis to be Highlighted in a Late-Breaking Presentation at The Liver Meeting® 2024

INTEGRIS-PSC to be featured in an oral presentation on Monday, November 18 SOUTH SAN FRANCISCO, Calif., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage...

Pliant Therapeutics Appoints Gary Palmer, M.D. as Senior Vice President of Medical Affairs

Former Bristol Myers Squibb Global Medical Affairs Lead brings over 25 years of experience to Pliant SOUTH SAN FRANCISCO, Calif., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
11.39.7232610321613.3715.813.19549947914.57035531CS
40.332.3012552301314.3416.111.7653726413.52220466CS
121.7913.89751552812.8816.110.3245088013.14863138CS
262.2918.497576736712.3816.110.2949952812.57953324CS
520.372.5874125874114.319.6210.2945927113.88001479CS
1561.3810.383747178313.2936.643.96562690319.24693422CS
260-7.83-34.822.543.923.96545779519.9424937CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
CTNTCheetah Net Supply Chain Service Inc
US$ 5.53
(195.72%)
107.05M
ZJKZJK Industrial Company Ltd
US$ 15.01
(136.75%)
20.23M
GWAVGreenwave Technology Solutions Inc
US$ 0.649325
(77.90%)
389.87M
JANXJanux Therapeutics Inc
US$ 62.685
(56.01%)
5.24M
JYDJayud Global Logistics Ltd
US$ 1.0411
(55.36%)
9.16M
REVBRevelation Biosciences Inc
US$ 0.5315
(-44.05%)
3.79M
STSSSharps Technology Inc
US$ 2.13
(-36.49%)
361.44k
OMEXOdyssey Marine Exploration Inc
US$ 0.4912
(-34.08%)
3.47M
GELSGelteq Ltd
US$ 2.703
(-29.25%)
224.91k
CYCNCyclerion Therapeutics Inc
US$ 1.67
(-28.63%)
259.85k
GWAVGreenwave Technology Solutions Inc
US$ 0.649325
(77.90%)
389.93M
SMCISuper Micro Computer Inc
US$ 41.2199
(-1.86%)
167.58M
CTNTCheetah Net Supply Chain Service Inc
US$ 5.53
(195.72%)
108.6M
CHRSCoherus BioSciences Inc
US$ 1.9299
(40.87%)
101.99M
NVDANVIDIA Corporation
US$ 139.30
(0.48%)
99.05M

PLRX Discussion

게시물 보기
게시물을 찾을 수 없습니다

최근 히스토리

Delayed Upgrade Clock